DFDA

Clinical Trials for Type 2 Diabetes

Focusing on: Metformin

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 1576 results.

Page 1 of 158
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
Completed
Study Type: INTERVENTIONAL
Phase: PHASE1
Enrollment: 26
Age: From 19 Years
Gender: MALE
Locations: Chonbuk National University Hospital
View Study Details
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers
Completed
Study Type: INTERVENTIONAL
Phase: PHASE1
Enrollment: 26
Age: From 19 Years
Gender: MALE
Locations: Chonbuk National University Hospital
View Study Details
Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets
Withdrawn
Interventions:GlucophageGlucophage
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: N/A
Age: From 18 Years
Gender: ALL
Locations: N/A
View Study Details
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
UnknownLast Known: RECRUITING
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 44
Age: 30 Years - 80 Years
Gender: ALL
Locations: ikfe GmbH
Join Study
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Completed
Study Type: INTERVENTIONAL
Phase: NA
Enrollment: 78
Age: 18 Years - 70 Years
Gender: ALL
Locations: Washington University in St. Louis
Has Results
View Study Details
Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes
Completed
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 186
Age: 35 Years - 75 Years
Gender: ALL
Locations: Galyawa Teaching Center for Diabetes and Endocrinology
View Study Details
Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes
Completed
Study Type: INTERVENTIONAL
Phase: PHASE2
Enrollment: 214
Age: 18 Years - 70 Years
Gender: ALL
Locations: Clinical Pharmacology of Miami
View Study Details
PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy
Completed
Interventions:Metformin
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 750
Age: 18 Years - 80 Years
Gender: ALL
Locations: N/A
View Study Details
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
Completed
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 114
Age: 18 Years - 80 Years
Gender: ALL
Locations: N/A
Has Results
View Study Details
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
Completed
Study Type: INTERVENTIONAL
Phase: PHASE3
Enrollment: 171
Age: From 20 Years
Gender: ALL
Locations: N/A
View Study Details